Drug Trial Radar · NCT06683352
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
Last checked: Nov 20, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,353
Actual
Start
Nov 11, 2024
Primary completion
Jul 15, 2025
Study completion Jul 15, 2025
Sponsor
- Lead sponsor
- BioNTech SEIndustry
- Sponsor type
- Industry
- Collaborators
- Pfizer
- First posted
- Nov 12, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is to learn about flu and COVID vaccines, either alone or when mixed together. Healthy people aged 18 or older can join. Participants will get one shot in each arm, either a flu or COVID vaccine, alone or mixed. The study lasts about 6 months, and participants need to visit the research site at least 3 times.
Conditions
- Influenza,Human
- COVID-19
Interventions
Investigational Influenza VaccineBiological
Investigational Influenza Vaccine
COVID-19 VaccineBiological
Pfizer-BioNTech COVID-19 Vaccine
Investigational Influenza/COVID-19 VaccineCombination product
Combined investigational influenza and Pfizer-BioNTech COVID-19 Vaccine
Licensed Influenza Vaccine 1Biological
Licensed Influenza Vaccine 1
Licensed Influenza Vaccine 2Biological
Licensed Influenza Vaccine 2
PlaceboOther
Saline
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohort 1: Percentage of Participants With Any Local Reactions for up to 7 Days Following VaccinationTime frame: From Day 1 through Day 7 after Vaccination [Vaccination on Day 1]
- Cohort 2: Percentage of Participants With Any Local Reactions for up to 7 Days Following VaccinationTime frame: From Day 1 through Day 7 after Vaccination [Vaccination on Day 1]
- Cohort 1: Percentage of Participants With Any Systemic Events for up to 7 Days Following VaccinationTime frame: From Day 1 through Day 7 after Vaccination [Vaccination on Day 1]
- Cohort 2: Percentage of Participants With Any Systemic Events for up to 7 Days Following VaccinationTime frame: From Day 1 through Day 7 after Vaccination [Vaccination on Day 1]
- Cohort 1: Percentage of Participants Reporting Adverse Events (AEs) From Vaccination Through 1 Month After VaccinationTime frame: From Vaccination on Day 1 through 1 month after Vaccination [Vaccination on Day 1]
- Cohort 2: Percentage of Participants Reporting AEs From Vaccination Through 1 Month After VaccinationTime frame: From Vaccination on Day 1 through 1 month after Vaccination [Vaccination on Day 1]
- Cohort 1: Percentage of Participants Reporting SAEs From Vaccination Through 6 Months After VaccinationTime frame: From Vaccination on Day 1 through 6 Months after Vaccination [Vaccination on Day 1]
- Cohort 2: Percentage of Participants Reporting SAEs From Vaccination Through 6 Months After VaccinationTime frame: From Vaccination on Day 1 through 6 Months after Vaccination [Vaccination on Day 1]
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
Orange County Research Center
Lake Forest, California
Artemis Institute for Clinical Research
San Diego, California
Diablo Clinical Research, Inc.
Walnut Creek, California
Clinical Research Consulting
Milford, Connecticut
Indago Research & Health Center, Inc
Hialeah, Florida
Miami Dade Medical Research Institute, LLC
Miami, Florida
Palm Springs Community Health Center
Miami Lakes, Florida
Headlands Research Orlando
Orlando, Florida
Clinical Research Atlanta
Stockbridge, Georgia
East-West Medical Research Institute
Honolulu, Hawaii
Clinical Research Professionals
Chesterfield, Missouri
Bio-Kinetic Clinical Applications, LLC dba QPS-MO
Springfield, Missouri
Bio-Kinetic Clinical Applications, LLC dba QPS-MO-Screening and Recruitment Center
Springfield, Missouri
Velocity Clinical Research, Omaha
Omaha, Nebraska
Las Vegas Clinical Trials
Las Vegas, Nevada
ActivMed Practices & Research, LLC.
Portsmouth, New Hampshire
DM Clinical Research- Cyfair
Houston, Texas
SMS Clinical Research
Mesquite, Texas
Dynamed Clinical Research, LP d/b/a DM Clinical Research
Tomball, Texas
J. Lewis Research, Inc. / Foothill Family Clinic
Salt Lake City, Utah
J. Lewis Research, Inc. / Foothill Family Clinic South
Salt Lake City, Utah
Charlottesville Medical Research
Charlottesville, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.